{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T01:14:29Z","timestamp":1771463669852,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.vaccine.2021.10.027","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T18:38:27Z","timestamp":1634841507000},"page":"7230-7237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["BCG-induced immunity profiles in household contacts of leprosy patients differentiate between protection and disease"],"prefix":"10.1016","volume":"39","author":[{"given":"Anouk","family":"van Hooij","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan J.F.","family":"van den Eeden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marufa","family":"Khatun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Soren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kees L.M.C.","family":"Franken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Chandra Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khorshed","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abu Sufian","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Hendrik","family":"Richardus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8555-2872","authenticated-orcid":false,"given":"Annemieke","family":"Geluk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2021.10.027_b0005","doi-asserted-by":"crossref","first-page":"e2544","DOI":"10.1371\/journal.pntd.0002544","article-title":"On the age of leprosy","volume":"8","author":"Han","year":"2014","journal-title":"PLoS NeglTrop Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2021.10.027_b0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.tim.2012.06.002","article-title":"New pathways of protective and pathological host defense to mycobacteria","volume":"20","author":"Ottenhoff","year":"2012","journal-title":"Trends Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2021.10.027_b0015","first-page":"24","article-title":"Global leprosy (Hansen disease) update, 2019: time to step-up prevention initiatives","volume":"95","author":"WHO","year":"2020","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2021.10.027_b0020","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clindermatol.2014.07.008","article-title":"Mechanisms of nerve injury in leprosy","volume":"33","author":"Scollard","year":"2015","journal-title":"Clin Dermatol"},{"issue":"4","key":"10.1016\/j.vaccine.2021.10.027_b0025","doi-asserted-by":"crossref","first-page":"e0003658","DOI":"10.1371\/journal.pntd.0003658","article-title":"The missing millions: a threat to the elimination of leprosy","volume":"9","author":"Smith","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2021.10.027_b0030","first-page":"1","article-title":"Huidafwijkingen en polyneuropathie: denk aan lepra","author":"Vermazeren-van Roij","year":"2015","journal-title":"Neth J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2021.10.027_b0035","doi-asserted-by":"crossref","first-page":"142","DOI":"10.47276\/lr.86.2.142","article-title":"Current knowledge on Mycobacterium leprae transmission: a systematic literature review","volume":"86","author":"Bratschi","year":"2015","journal-title":"Lepr Rev"},{"issue":"6823","key":"10.1016\/j.vaccine.2021.10.027_b0040","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/35059006","article-title":"Massive gene decay in the leprosy bacillus","volume":"409","author":"Cole","year":"2001","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2021.10.027_b0045","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1038\/s41598-019-39746-6","article-title":"Detection of Mycobacterium leprae DNA in soil: multiple needles in the haystack","volume":"9","author":"Ti\u00f3-Coma","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2021.10.027_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006532","article-title":"Evidence of zoonotic leprosy in Para, Brazilian Amazon, and risks associated with human contact or consumption of armadillos","volume":"12","author":"da Silva","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"17","key":"10.1016\/j.vaccine.2021.10.027_b0055","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1056\/NEJMoa1010536","article-title":"Probable zoonotic leprosy in the southern United States","volume":"364","author":"Truman","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2021.10.027_b0060","doi-asserted-by":"crossref","first-page":"310","DOI":"10.47276\/lr.75.4.310","article-title":"Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions","volume":"75","author":"Moet","year":"2004","journal-title":"Lepr Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2021.10.027_b0065","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S2214-109X(20)30396-X","article-title":"Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme","volume":"9","author":"Richardus","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2021.10.027_b0070","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/1471-2334-13-456","article-title":"The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study)","volume":"13","author":"Richardus","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.10.027_b0075","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1186\/s12889-019-7868-9","article-title":"A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities","volume":"19","author":"Faust","year":"2019","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2021.10.027_b0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/erv.09.161","article-title":"BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control","volume":"9","author":"Merle","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2021.10.027_b0085","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1473-3099(06)70412-1","article-title":"The role of BCG in prevention of leprosy: a meta-analysis","volume":"6","author":"Setia","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2021.10.027_b0090","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0035-9203(88)90003-X","article-title":"Leprosy in Malawi. 2. Background, design and prospects of the Karonga Prevention Trial, a leprosy vaccine trial in northern Malawi","volume":"82","author":"Fine","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2021.10.027_b0095","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fimmu.2018.00308","article-title":"Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application","volume":"9","author":"Coppola","year":"2018","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2021.10.027_b0100","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.trstmh.2008.04.015","article-title":"Effectiveness of BCG vaccination among leprosy contacts: a cohort study","volume":"102","author":"D\u00fcppre","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2021.10.027_b0105","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/s41598-021-81643-4","article-title":"Leprosy incidence and risk estimates in a 33-year contact cohort of leprosy patients","volume":"11","author":"Hacker","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2021.10.027_b0110","article-title":"Effectiveness of single dose rifampicin after BCG-vaccination to prevent leprosy in close contacts of patients with newly diagnosed leprosy: a cluster randomized controlled trial","author":"Richardus","year":"2019","journal-title":"Int J Infect Dis: IJID: Off Publ Int Soc Infect Dis."},{"issue":"13","key":"10.1016\/j.vaccine.2021.10.027_b0115","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.vaccine.2015.02.017","article-title":"Clinical manifestations of leprosy after BCG vaccination: An observational study in Bangladesh","volume":"33","author":"Richardus","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.10.027_b0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.smim.2018.06.003","article-title":"Correlates of immune exacerbations in leprosy","volume":"39","author":"Geluk","year":"2018","journal-title":"Semin Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2021.10.027_b0125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41577-020-0337-y","article-title":"BCG-induced trained immunity: can it offer protection against COVID-19?","volume":"20","author":"O\u2019Neill","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"6490","key":"10.1016\/j.vaccine.2021.10.027_b0130","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.vaccine.2021.10.027_b0135","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200678","article-title":"The many faces of the anti-COVID immune response","volume":"217","author":"Vardhana","year":"2020","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.vaccine.2021.10.027_b0140","doi-asserted-by":"crossref","first-page":"e2338","DOI":"10.1371\/journal.pntd.0002338","article-title":"CD4+ Th17 Cells Discriminate Clinical Types and Constitute a Third Subset of Non Th1, Non Th2 T Cells in Human Leprosy","volume":"7","author":"Saini","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2021.10.027_b0145","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1128\/iai.61.8.3482-3489.1993","article-title":"Cytokine production at the site of disease in human tuberculosis","volume":"61","author":"Barnes","year":"1993","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2021.10.027_b0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/imr.12966","article-title":"In search of biomarkers for leprosy by unraveling the host immune response to Mycobacterium leprae","volume":"301","author":"Hooij","year":"2021","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2021.10.027_b0155","first-page":"255","article-title":"Classification of leprosy according to immunity. A five-group system","volume":"34","author":"Ridley","year":"1966","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.vaccine.2021.10.027_b0160","doi-asserted-by":"crossref","first-page":"34260","DOI":"10.1038\/srep34260","article-title":"Quantitative lateral flow strip assays as user-friendly tools to detect biomarker profiles for leprosy","volume":"6","author":"van Hooij","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2021.10.027_b0165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ebiom.2019.08.009","article-title":"Application of new host biomarker profiles in quantitative point-of-care tests facilitates leprosy diagnosis in the field","volume":"47","author":"van Hooij","year":"2019","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.vaccine.2021.10.027_b0170","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.4049\/jimmunol.1103452","article-title":"New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy","volume":"188","author":"Geluk","year":"2012","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.10.027_b0175","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1038\/s41598-017-07803-7","article-title":"Field-friendly serological tests for determination of M. leprae-specific antibodies","volume":"7","author":"van Hooij","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2021.10.027_b0180","doi-asserted-by":"crossref","first-page":"102006","DOI":"10.1016\/j.isci.2020.102006","article-title":"Prototype multi-biomarker test for point-of-care leprosy diagnostics","volume":"24","author":"van Hooij","year":"2021","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.vaccine.2021.10.027_b0185","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1128\/CMR.19.2.338-381.2006","article-title":"The continuing challenges of leprosy","volume":"19","author":"Scollard","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2021.10.027_b0190","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/s12879-018-3402-4","article-title":"An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP+","volume":"18","author":"Mieras","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2021.10.027_b0195","doi-asserted-by":"crossref","first-page":"e0008521","DOI":"10.1371\/journal.pntd.0008521","article-title":"Leprosy post-exposure prophylaxis in the Indian health system: A cost-effectiveness analysis","volume":"14","author":"Tiwari","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2021.10.027_b0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijid.2019.08.035","article-title":"Effectiveness of single-dose rifampicin after BCG vaccination to prevent leprosy in close contacts of patients with newly diagnosed leprosy: A cluster randomized controlled trial","volume":"88","author":"Richardus","year":"2019","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.10.027_b0205","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1186\/s12879-019-4649-0","article-title":"Protocol, rationale and design of PEOPLE (Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar): a cluster randomized trial on effectiveness of different modalities of implementation of post-exposure prophylaxis of leprosy contacts","volume":"19","author":"Ortuno-Gutierrez","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2021.10.027_b0210","doi-asserted-by":"crossref","first-page":"e0004331","DOI":"10.1371\/journal.pntd.0004331","article-title":"Leprosy diagnostic test development as a prerequisite towards elimination: Requirements from the user's perspective","volume":"10","author":"Roset Bahmanyar","year":"2016","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.vaccine.2021.10.027_b0215","series-title":"Guidelines for the diagnosis, treatment and prevention of leprosy","author":"World Health Organization","year":"2018"},{"issue":"7647","key":"10.1016\/j.vaccine.2021.10.027_b0220","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/bmj.39500.885752.BE","article-title":"Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial","volume":"336","author":"Moet","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2021.10.027_b0225","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3389\/fimmu.2018.00629","article-title":"BCG and adverse events in the context of leprosy","volume":"9","author":"Richardus","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2021.10.027_b0230","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.3389\/fimmu.2020.01811","article-title":"Household Contacts of Leprosy Patients in Endemic Areas Display a Specific Innate Immunity Profile","volume":"11","author":"van Hooij","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2021.10.027_b0235","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1172\/JCI97508","article-title":"Mycobacterial growth inhibition is associated with trained innate immunity","volume":"128","author":"Joosten","year":"2018","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.vaccine.2021.10.027_b0240","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.4049\/jimmunol.1401151","article-title":"Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features","volume":"193","author":"Arlehamn","year":"2014","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"24","key":"10.1016\/j.vaccine.2021.10.027_b0245","doi-asserted-by":"crossref","first-page":"38378","DOI":"10.18632\/oncotarget.16386","article-title":"Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.vaccine.2021.10.027_b0250","doi-asserted-by":"crossref","first-page":"e1000158","DOI":"10.1371\/journal.ppat.1000158","article-title":"VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis","volume":"4","author":"Stanley","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2021.10.027_b0255","doi-asserted-by":"crossref","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: A program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.vaccine.2021.10.027_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(10)05001-7","article-title":"Learning from leprosy: insight into the human innate immune response","volume":"105","author":"Montoya","year":"2010","journal-title":"Adv Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21013487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21013487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:04:19Z","timestamp":1759403059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21013487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":52,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0264410X21013487"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.10.027","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCG-induced immunity profiles in household contacts of leprosy patients differentiate between protection and disease","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}